Cigna reaffirms 2026 outlook at Investor Day, targets 10–14% adjusted EPS CAGR through 2030

The Cigna Group used its Investor Day on Wednesday to lock in this year’s financial guide and sketch a longer runway for earnings growth. In a press release furnished on Form 8-K, the company reaffirmed full-year 2026 consolidated adjusted revenues of about $280 billion and adjusted EPS of at least $30.45, while introducing a long-term adjusted EPS compound annual growth target of 10% to 14% through 2030.

Management also restated segment pieces of the 2026 outlook: Evernorth Health Services adjusted income from operations of at least $6.9 billion, Cigna Healthcare adjusted income from operations of at least $4.55 billion, and a Cigna Healthcare medical care ratio of 83.7% to 84.7%. Through year-end 2030, the company pointed to roughly $50 billion in cumulative operating cash flow alongside the adjusted EPS growth band.

Cigna framed the day around a “Lead to One” vision that CEO Brian Evanko described as unifying the enterprise around “personalization at scale” to improve affordability and the patient experience. The release said the strategy rests on delivering core growth from a deliberately shaped portfolio (Cigna Healthcare plus Evernorth Specialty & Care Services and Pharmacy Benefit Services), leveraging complex-care capabilities across clinical expertise, data, technology, and AI, and executing with discipline on operations and capital.

As part of that push, Cigna announced a new $3 billion multi-year series of modernization and productivity initiatives it said will focus on process modernization, AI-enabled tools for colleagues, and supplier and vendor management. CFO Ann Dennison said the long-term growth targets are supported by those initiatives, which the company described as self-funding. Separately, The Cigna Group Foundation said it is launching a $10.5 million, three-year grant program aimed at community support for patients and caregivers facing non-clinical barriers to treatment.

Shares of CI were recently near $273, down about 0.8% from Tuesday’s close, and roughly 2% lower year to date.

By the numbers

• 2026 adjusted revenues guide: ~$280 billion (reaffirmed)
• 2026 adjusted EPS guide: at least $30.45 (reaffirmed)
• Evernorth adj. income from ops: ≥$6.9 billion
• Cigna Healthcare adj. income from ops: ≥$4.55 billion
• Medical care ratio outlook: 83.7%–84.7%
• Long-term adj. EPS CAGR target: 10–14% through 2030; ~$50 billion cumulative OCF; $3 billion modernization/productivity program

Sources

1. The Cigna Group Form 8-K (Item 7.01), accepted Sept. 30, 2026 7:12:36 a.m. ET, accession 0001140361-26-038056
2. The Cigna Group Form 8-K Exhibit 99.1 (Investor Day press release), accession 0001140361-26-038056

This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.

Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.